Amphastar Pharmaceuticals (AMPH) Shares Outstanding (Weighted Average) (2013 - 2026)

Amphastar Pharmaceuticals' Shares Outstanding (Weighted Average) history runs 14 years deep, the most recent figure standing at $45.3 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Weighted Average) fell 4.87% year-over-year to $45.3 million; the TTM figure through Mar 2026 stood at $45.3 million (down 4.87% YoY), while the FY2025 annual figure was $46.7 million, down 3.48% from the prior year.
• Shares Outstanding (Weighted Average) was $45.3 million for Q1 2026 at Amphastar Pharmaceuticals, down from $46.7 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $48.9 million in Q3 2022 to a low of $45.3 million in Q1 2026.
• Historically, Shares Outstanding (Weighted Average) has averaged $47.9 million across 5 years, with a median of $48.2 million in 2024.
• The sharpest annual moves came in 2022 and 2026: Shares Outstanding (Weighted Average) climbed 2.4% in 2022, then declined 4.87% in 2026.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $48.6 million in 2022, then fell by 0.59% to $48.3 million in 2023, then climbed by 0.34% to $48.4 million in 2024, then declined by 3.48% to $46.7 million in 2025, then slipped by 3.04% to $45.3 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $45.3 million (Q1 2026), $46.7 million (Q4 2025), and $46.5 million (Q3 2025), per Business Quant data.